Navigation Links
Duke to co-lead NIH research network on antibacterial resistance
Date:6/3/2013

DURHAM, N.C. -- Investigators at Duke Medicine and the University of California, San Francisco (UCSF) have been selected to oversee a nationwide research program on antibacterial resistance, which includes a focus on the growing unmet challenges associated with methicillin-resistant Staphylococcus aureus (MRSA) and E. coli.

The research team will direct the allocation of a federal grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Duke has been awarded $2 million in initial funding to launch the network; total funding for the award will reach at least $62 million through 2019.

The grant creates a network of researchers who will design, prioritize, implement and manage a clinical research agenda to address antibacterial resistance, an issue that has been identified as one of the leading threats to human health worldwide. The group's goal is to develop new approaches that can benefit patients.

"Antibacterial resistance is an incredibly complex problem because of a convergence of issues: a dwindling pipeline of new products to treat infections, and a growing threat of antibiotic-resistant bacteria," said Vance Fowler, Jr., M.D., MHS, professor of medicine at Duke and one of the network's two principal investigators.

Antibiotics have been used for the past 70 years, significantly reducing illness and death from bacterial infections. However, some bacteria have adapted to the antibiotics designed to kill them, leaving the drugs less effective.

"Infections caused by drug-resistant bacteria are challenging to treat because one often has to rely on second- or third-line antibiotics, the effectiveness of which is not well known, or if known, is less than drugs of choice. These antibiotics may be more toxic, as well," said co-principal investigator Henry "Chip" Chambers, M.D., professor of medicine at UCSF and chief of the Division of Infectious Diseases at San Francisco General Hospital and Trauma Center.

To address this growing issue, NIAID created the Antibacterial Resistance Leadership Group. Led by researchers at the Duke Clinical Research Institute (DCRI) in collaboration with UCSF, the group serves as a central hub to identify, prioritize, execute and disseminate clinical research on antibacterial resistance. The global scientific community will be invited to submit proposals for research projects on antibacterial resistance, which the Antibacterial Resistance Leadership Group will review and fund based on alignment with the group's priorities.

"One of the strengths that we've tried to leverage in this project is the formidable expertise of a number of investigators across the United States," Fowler said. "We want to partner with these smart, talented, and driven investigators in the key areas we've identified."

The research effort will focus on four priorities:

  • Gram-negative bacteria, such as E. coli;
  • Gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus, or MRSA;
  • Stewardship and infection control, which will determine how to best prevent infections, prescribe antibiotics and avoid overuse;
  • Devices and diagnostics, which will aim to reduce the amount of time it takes to determine what type of bacteria are causing infection.

"Gram-negative bacteria are front-and-center in our research agenda because the need for new treatments is greatest with them," Fowler said. He also stressed the importance of improving diagnostics, noting that technology will likely play a role in helping identify pathogens more quickly.

"For most bacterial infections, our diagnostic strategies are still fundamentally the same as they were 100 years ago," Fowler said. "We're still isolating, culturing and identifying bacteria that have been grown from a clinical sample. Each of those steps takes time, and clinicians don't always have the luxury of time.

"Reducing the time to knowledge would have the dual benefit of improving care for individual patients, but on a broader scale can serve to reduce the need for unnecessary antibiotics," Fowler said.

In addition to the four research priorities, the Antibacterial Resistance Leadership Group will focus attention on pharmacokinetics, or how drugs behave in patients, and antibacterial resistance in children.

The group will also work to cultivate the next generation of experts in antibacterial resistance by placing an emphasis on mentoring and training.

The group represents a partnership between NIAID staff and the antibacterial resistance research community, and will have the capacity to rapidly respond to emerging priority clinical research questions in antibacterial resistance.

The Antibacterial Resistance Leadership Group builds on a model of successful research networks led by Duke, including the Pediatric Trials Network and the NIAID-funded Center for HIV/AIDS Vaccine Immunology.

The structure of the DCRI also gives investigators the ability to perform complex clinical trials necessary for antibacterial resistance research.

"The track record that DCRI brings to the table for networks, particularly NIH-funded networks, is unprecedented," Fowler said.


'/>"/>

Contact: Rachel Harrison
919-419-5069
Duke University Medical Center
Source:Eurekalert

Related medicine news :

1. Sofia University Professor Karen Erlichman to Co-Lead Spiritual Directors International Leadership Institute 2013
2. NIH to fund clinical research network on antibacterial resistance
3. Researchers identify genetic signature of deadly brain cancer
4. Dartmouth researchers test safety of Nivolumab in kidney cancer
5. North America Leads the Largest Market Share of the Bioinformatics Market Says New Research Report by MarketsandMarkets
6. New Hepatitis C Clinical Trial Now Enrolling at Avail Clinical Research near Orlando, Florida; Accepting M/F Patients with Hep C Age 18-65
7. Low Back Pain Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; Accepting M/F Patients with Chronic Low Back Pain Age 18-80
8. Monoclonal Antibodies Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research
9. Biscuit Production in China Industry Research Report – Now Available from IBISWorld
10. The Mesothelioma Applied Research Foundation Opened its 2013 Grant Cycle
11. Research Shows How Ritalin Affects Brains of Kids With ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... ... and pharmaceutical organizations to build intelligent, connected applications, was named the best Sales ... , The winner announcement was made today by the Software & Information ...
(Date:12/2/2016)... ... December 02, 2016 , ... ‘Tis the season for giving! Today, 20 ... the National Family Partnership and the Drug Enforcement Administration as part of the National ... the 10 winning schools who decorated their campuses with this year’s Red Ribbon Week ...
(Date:11/30/2016)... Northridge, CA (PRWEB) , ... November 30, 2016 ... ... Elyson, announce that they now offer a comprehensive in-house dental plan for all ... dentists have developed a plan that gives patients a number of perks, including ...
(Date:11/30/2016)... PALMYRA, Wisconsin (PRWEB) , ... November 30, 2016 ... ... inclusion in the 2016 Deloitte Wisconsin 75, an annual ranking and recognition of ... consecutive year on the list, having ranked from 2008-2016. In addition, Standard Process ...
(Date:11/30/2016)... Chino Hills, CA (PRWEB) , ... November 30, ... ... in eating disorder and mental health treatment has announced the opening of a ... specialized residential treatment for girls with mental health issues such as severe anxiety, ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... FRANCISCO , Dec. 2, 2016  PipelineRx, a ... telepharmacy, will be offering demonstrations of its SaaS-based ... Society of Health-System Pharmacists 2016 Midyear Clinical Meeting ... Vegas . With nearly 300 hospital clients ... services and technology designed to dramatically improve pharmacy ...
(Date:12/2/2016)... December 2, 2016 On Thursday, ... honored excellence in research, development and innovation in the ... dinner was held in the presence of Sergey Tsyb, ... Russian Federation , Natalia Sanina, First Vice ... Murashko , Head of Roszdravnadzor, National Service of Control ...
(Date:12/2/2016)...  Eli Lilly and Company (NYSE: LLY ... provide updated financial guidance for 2016 on Thursday, December ... on that day with the investment community and media ... The conference call will begin at 10 a.m. ET. ... live webcast of the conference call through a link ...
Breaking Medicine Technology: